DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

SECC Scottish Exhibition and Conference Centre

2017 年 03 月 29 日 9:00 上午 - 2017 年 03 月 31 日 5:30 下午

Exhibition Way, Glasgow, G3 8YW, United Kingdom

29th Annual EuroMeeting

The EuroMeeting provides experts from all disciplines of healthcare product development a platform to debate and find solutions to the challenges of an ever-evolving healthcare system.

Brexit – Where Are We Now?

Session Chair(s)

Alan  Morrison, PHD

Alan Morrison, PHD

Vice President Regulatory Affairs Intl

MSD, United Kingdom

Brexit will impact on the established European Regulatory environment over the next decade. It may create potential new opportunities for deeper integration of the operational processes of the EU Regulatory Network, however, and may also create potential risks for regulatory business continuity that could be harmful to patients. This session will provide an overview of the current state of play of the political process from a UK as well as an EU perspective. It will seek views from important healthcare stakeholder groups, such as industry, regulators and patients on the longer term impact as well as practical aspects that need to be considered to avoid unintended consequences for EU and UK citizens while fully respecting the political decisions. Multiple stakeholder perspectives will look at the post Brexit scenario from a UK perspective but also from the EU and global regulatory environment view. Key stakeholders will discuss in a panel debate the impact of the expected changes on their organisation and how they will capitalise on potential opportunities or mitigate potential risks to the regulatory business.

Speaker(s)

Virginia  Acha, PHD, MSC

Panel Discussion

Virginia Acha, PHD, MSC

MSD, United States

Global Lead, Global Regulatory Policy

Karl  Broich, DrMed

Panel Discussion

Karl Broich, DrMed

Federal Institute for Drugs and Medical Devices (BfArM), Germany

President

Elizabeth  Kuiper, MA

Panel Discussion

Elizabeth Kuiper, MA

European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium

Executive Director, Public Affairs

Jonathan  Mogford

Panel Discussion

Jonathan Mogford

Medicines and Healthcare products Regulatory Agency (MHRA),, United Kingdom

Director of Policy

Nick  Meade, MSC

Panel Discussion

Nick Meade, MSC

Genetic Alliance UK, United Kingdom

Director of Policy

Melanie  Carr

Melanie Carr

European Medicines Agency, Netherlands

Head of Stakeholders and Communication Division

Saad  Shakir, MD, FFPM, FISPE, FRCP

Panel Discussion

Saad Shakir, MD, FFPM, FISPE, FRCP

ADROITVIGILANCE, United Kingdom

Pharmacovigilance Physician and Pharmacoepidemiologist

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。